Wang CH, Lin RC, Hsu HY, Tseng YT, et al. Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term population-based cohort study. PLoS One 2022;17:e0271790.
PMID: 35862398